Development of Fourth Hurdle Policies Around the World
- 1 August 2004
- book chapter
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewBMJ, 2003
- A Paclitaxel-Eluting Stent for the Prevention of Coronary RestenosisNew England Journal of Medicine, 2003
- Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosisBMJ, 2003
- After Nice: where now for health policy in the European Union?Journal of the Royal Society of Medicine, 2003
- Reforming Pharmaceutical Policies in the European Union: A “Penguin Effect”?International Journal of Health Services, 2003
- Pricing and reimbursement of pharmaceuticals in PortugalThe European Journal of Health Economics, 2002
- Developing the Revised NICE Appraisal Technical Guidance to Manufacturers and SponsorsPharmacoEconomics, 2002
- Health Economic Guidelines—Similarities, Differences and Some ImplicationsValue in Health, 2001
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Lessons from international experience in controlling pharmaceutical expenditure III: regulating industryBMJ, 1996